首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2
Authors:Renée VancraenenbroeckEvy Lobbestael  Stephen D WeeksSergei V Strelkov  Veerle BaekelandtJean-Marc Taymans  Marc De Maeyer
Institution:
  • a Laboratory for Biomolecular Modelling; Division of Biochemistry, Molecular and Structural Biology; Department of Chemistry; Katholieke Universiteit Leuven, Belgium
  • b Laboratory for Neurobiology and Gene Therapy; Division of Molecular Medicine; Department of Neurosciences; Katholieke Universiteit Leuven, Belgium
  • c Laboratory for Biocrystallography; Department of Pharmaceutical and Pharmacological Sciences; Katholieke Universiteit Leuven, Belgium
  • Abstract:Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson's disease. Much research effort has been directed towards the catalytic core region of LRRK2 composed of GTPase (ROC, Ras of complex proteins) and kinase domains and a connecting COR (C-terminus of ROC) domain. In contrast, the precise functions of the protein-protein interaction domains, such as the leucine-rich repeat (LRR) domain, are not known. In the present study, we modeled the LRRK2 LRR domain (LRRLRRK2) using a template assembly approach, revealing the presence of 14 LRRs. Next, we focused on the expression and purification of LRRLRRK2 in Escherichia coli. Buffer optimization revealed that the protein requires the presence of a zwitterionic detergent, namely Empigen BB, during solubilization and the subsequent purification and characterization steps. This indicates that the detergent captures the hydrophobic surface patches of LRRLRRK2 thereby suppressing its aggregation. Circular dichroism (CD) spectroscopy measured 18% α-helices and 21% β-sheets, consistent with predictions from the homology model. Size exclusion chromatography (SEC) and dynamic light scattering measurements showed the presence of a single species, with a Stokes radius corresponding to the model dimensions of a protein monomer. Furthermore, no obvious LRRLRRK2 multimerization was detected via cross-linking studies. Finally, the LRRLRRK2 clinical mutations did not influence LRRLRRK2 secondary, tertiary or quaternary structure as determined via SEC and CD spectroscopy. We therefore conclude that these mutations are likely to affect putative LRRLRRK2 inter- and intramolecular interactions.
    Keywords:BS3  bis(sulfosuccinimidyl) suberate  CD  circular dichroism  Chaps  3-[(3-Cholamidopropyl)-dimethylammonio]-1-propanesulfonate  CL  cross-linking  DDM  d-maltopyranoside" target="_blank">n-Dodecyl-β-d-maltopyranoside  DLS  dynamic light scattering  DTT  dithiothreitol  EDC  1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride  EDTA  ethylene-diamine-tetra-acetic acid  EGS  ethylene glycol-bis(succinic acid N-hydroxysuccinimide ester)  HM  homology modeling  GA  glutaraldehyde  GuHCl  guanidine hydrochloride  IEX  ion exchange  IMAC  immobilized metal ion affinity chromatography  IPTG  d-thiogalacto-pyranoside" target="_blank">isopropyl-β-d-thiogalacto-pyranoside  LB  Luria Bertani  MW  molecular weight  rASA  relative accessible surface area  RStokes  Stokes radius  SDS  sodium dodecyl sulfate  SDS-PAGE  SDS-polyacrylamide gel electrophoresis  SEC  size exclusion chromatography  S-EGS  ethylene glycol-bis(succinic acid N-hydroxysuccinimide ester)  S-SDA  sulfosuccinimidyl 6-(4  4&prime  -azipentanamido) hexanoate  UV  ultraviolet
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号